- Home
- ONC
as 10-24-2025 3:49pm EST
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
| Founded: | 2010 | Country: | Switzerland |
| Employees: | N/A | City: | BASEL |
| Market Cap: | 34.8B | IPO Year: | N/A |
| Target Price: | $350.00 | AVG Volume (30 days): | 227.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 10 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $170.99 - $355.30 | Next Earning Date: | 11-06-2025 |
| Revenue: | $4,562,002,000 | Revenue Growth: | 47.33% |
| Revenue Growth (this year): | 887.89% | Revenue Growth (next year): | 22.45% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
Business Wire
5 days ago
BeOne Medicines to Announce Third Quarter 2025 Financial Results on November 6
Business Wire
7 days ago
BeOne Medicines Presents New Data on TEVIMBRA in Lung Cancer at ESMO 2025
Investor's Business Daily
23 days ago
How BeOne Medicines, An IBD 50 Stock, Is Taking On Big Names In Cancer Treatment
Insider Monkey
25 days ago
BeOne Medicines (ONC) Gains Barclays Overweight Rating Ahead of Key 2025 Data Readouts
Insider Monkey
a month ago
Here’s Why BeOne Medicines Ltd. (ONC) Declined in Q2
Simply Wall St.
a month ago
BeOne Medicines AG (NASDAQ:ONC) About To Shift From Loss To Profit
Barrons.com
a month ago
China’s Young Consumers Set the Global Trend. What They’re Buying Now.
Insider Monkey
a month ago
Citizens JMP Maintains a Buy Rating on BeOne Medicines (ONC)
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.